Ovarian Cysts Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cysts, including details on causes, treatment, symptoms, infertility.

Volume 8 (2011), Issue 5 (May)

1. Effect of dose escalation of metformin on clinical features, insulin sensitivity and androgen profile in polycystic ovary syndrome.
   Eur J Obstet Gynecol Reprod Biol, 156(1): 67-71. [Abstract] [Full-text]
2. Adipose tissue dysfunction in polycystic ovary syndrome.
   Curr Diab Rep, 11(3): 179-84. [Abstract] [Full-text]
3. Analysis of heart rate variability in polycystic ovary syndrome.
   Gynecol Endocrinol, 27(6): 443-7. [Abstract] [Full-text]
4. Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.
   J Clin Endocrinol Metab, 96(5): 1311-9. [Abstract] [Full-text]
5. The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.
   J Clin Endocrinol Metab, 96(5): E821-4. [Abstract] [Full-text]
6. Determinants of dyslipidaemia in probands with polycystic ovary syndrome and their sisters.
   Clin Endocrinol (Oxf), 74(6): 714-9. [Abstract] [Full-text]
7. Thyroid vein thrombosis in a young woman with methylenetetrahydrofolate reductase gene mutation receiving cyproterone acetate/ethinylestradiol treatment for polycystic ovary syndrome: a case report.
   Blood Coagul Fibrinolysis, 22(4): 331-3. [Abstract] [Full-text]
8. Selected metabolic and hormonal profiles during maintenance of spontaneous ovarian cysts in dairy cows.
   Reprod Domest Anim, 46(3): 448-54. [Abstract] [Full-text]
9. Cardiovascular disease risk characteristics of the main polycystic ovary syndrome phenotypes.
   Endocrine, 39(3): 272-7. [Abstract] [Full-text]
10. Abnormal expression of uncoupling protein-2 correlates with CYP11A1 expression in polycystic ovary syndrome.
    Reprod Fertil Dev, 23(4): 520-6. [Abstract] [Full-text]
11. Testosterone and mood dysfunction in women with polycystic ovarian syndrome compared to subfertile controls.
    J Psychosom Obstet Gynaecol, 32(2): 104-11. [Abstract] [Full-text]
12. Ovarian hypertension: polycystic ovary syndrome.
    Endocrinol Metab Clin North Am, 40(2): 433-49, ix-x. [Abstract] [Full-text]
13. Association of TRB3 Q84R polymorphism with polycystic ovary syndrome in Chinese women.
    Reprod Biol Endocrinol, 9: 46. [Abstract] [Full-text]
14. Reproductive outcome after letrozole versus laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome.
    Int J Gynaecol Obstet, 113(3): 218-21. [Abstract] [Full-text]
15. Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone.
    Reprod Biol Endocrinol, 9: 59. [Abstract] [Full-text]
16. Magnetic resonance manifestations of hyperreactio luteinalis.
    J Comput Assist Tomogr, 35(3): 343-6. [Abstract] [Full-text]
17. No difference in markers of adipose tissue inflammation between overweight women with polycystic ovary syndrome and weight-matched controls.
    Hum Reprod, 26(6): 1478-85. [Abstract] [Full-text]
18. Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis.
    Hum Reprod, 26(6): 1469-77. [Abstract] [Full-text]
19. The oligomenorrhoic phenotypes of polycystic ovary syndrome are characterized by a high visceral adiposity index: a likely condition of cardiometabolic risk.
    Hum Reprod, 26(6): 1486-94. [Abstract] [Full-text]
20. Is having polycystic ovary syndrome a predictor of poor psychological function including anxiety and depression?
    Hum Reprod, 26(6): 1399-407. [Abstract] [Full-text]
21. Diabetes and impaired glucose tolerance in patients with polycystic ovary syndrome--a long term follow-up.
    Hum Reprod, 26(6): 1462-8. [Abstract] [Full-text]
22. Comparison of MRI-assessed body fat content between lean women with polycystic ovary syndrome (PCOS) and matched controls: less visceral fat with PCOS.
    Hum Reprod, 26(6): 1495-500. [Abstract] [Full-text]
23. Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome.
    Acta Obstet Gynecol Scand, 90(6): 600-8. [Abstract] [Full-text]
24. A common polymorphism in the human aromatase gene alters the risk for polycystic ovary syndrome and modifies aromatase activity in vitro.
    Mol Hum Reprod, 17(6): 386-91. [Abstract] [Full-text]
25. Approach to the girl with early onset of pubic hair.
    J Clin Endocrinol Metab, 96(6): 1610-22. [Abstract] [Full-text]
26. Impact of laparoscopic ovarian drilling on anti-Müllerian hormone levels and ovarian stromal blood flow using three-dimensional power Doppler in women with anovulatory polycystic ovary syndrome.
    Fertil Steril, 95(7): 2342-6, 2346.e1. [Abstract] [Full-text]
27. Follicle-stimulating hormone suppressed excessive production of antimullerian hormone caused by abnormally enhanced promoter activity in polycystic ovary syndrome granulosa cells.
    Fertil Steril, 95(7): 2354-8, 2358.e1. [Abstract] [Full-text]
28. Hyperreactio luteinalis in pregnancy.
    Fertil Steril, 95(7): 2429.e1-3. [Abstract] [Full-text]
29. The effect of laparoscopic ovarian cystectomy versus coagulation in bilateral endometriomas on ovarian reserve as determined by antral follicle count and ovarian volume: a prospective randomized study.
    Fertil Steril, 95(7): 2247-50. [Abstract] [Full-text]
30. Endometrial gene expression in the window of implantation is altered in obese women especially in association with polycystic ovary syndrome.
    Fertil Steril, 95(7): 2335-41, 2341.e1-8. [Abstract] [Full-text]
31. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women.
    J Clin Endocrinol Metab, 96(6): E986-90. [Abstract] [Full-text]
32. Unfavorable hormonal, metabolic, and inflammatory alterations persist after menopause in women with PCOS.
    J Clin Endocrinol Metab, 96(6): 1827-34. [Abstract] [Full-text]
33. Extent of metabolic risk in adolescent girls with features of polycystic ovary syndrome.
    Fertil Steril, 95(7): 2347-53, 2353.e1. [Abstract] [Full-text]
34. Progesterone resistance in PCOS endometrium: a microarray analysis in clomiphene citrate-treated and artificial menstrual cycles.
    J Clin Endocrinol Metab, 96(6): 1737-46. [Abstract] [Full-text]
35. Harnessing expression data to identify novel candidate genes in polycystic ovary syndrome.
    PLoS One, 6(5): e20120. [Abstract] [Full-text]
36. A comparison of polysomnographic variables between adolescents with polycystic ovarian syndrome with and without the metabolic syndrome.
    Metab Syndr Relat Disord, 9(3): 191-6. [Abstract] [Full-text]
37. Energy metabolites in pre- and postpartum dairy cattle as predictors of reproductive disorders.
    Vet Rec, 168(21): 562. [Abstract] [Full-text]
38. Effect on ovarian reserve of laparoscopic bipolar electrocoagulation versus laparotomic hemostatic sutures during unilateral ovarian cystectomy.
    Int J Gynaecol Obstet, 114(1): 69-72. [Abstract] [Full-text]
39. Initial clinical experience using a novel laparoscopy assistant.
    Minim Invasive Ther Allied Technol, 20(3): 167-73. [Abstract] [Full-text]
40. Transvaginal aspiration of ovarian cysts: our experience over 121 cases.
    Minim Invasive Ther Allied Technol, 20(3): 155-9. [Abstract] [Full-text]
41. Lipin 1 gene polymorphisms in polycystic ovary syndrome.
    Horm Metab Res, 43(6): 427-32. [Abstract] [Full-text]

© 2004-2011 Ovarian Cysts Research Today. All Rights Reserved.